All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
| LYEL / Lyell Immunopharma, Inc.
|
|
|
|
|
|
|
|
| SPRO / Spero Therapeutics, Inc.
|
|
|
|
|
|
|
|
| OSCR / Oscar Health, Inc.
|
|
|
|
|
|
|
|
| PATH / UiPath Inc.
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| US29335V1061 / Enjoy Technology, Inc.
|
|
|
|
|
|
|
|
| ABNB / Airbnb, Inc.
|
|
|
|
|
|
|
|
| NVTAQ / Invitae Corporation
|
|
|
|
|
|
|
|
| US83088V1026 / Slack Technologies Inc
|
|
|
|
|
|
|
|
| KVSB / Khosla Ventures Acquisition Co II - Class A
|
|
|
|
|
|
|
|
| IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
| RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
| EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
| BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
| VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
| UBER / Uber Technologies, Inc.
|
|
|
|
|
|
|
|
| TSHA / Taysha Gene Therapies, Inc.
|
|
|
|
|
|
|
|
| VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TCRX / TScan Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CLOV / Clover Health Investments, Corp.
|
|
|
|
|
|
|
|
| SQZ / SQZ Biotechnologies Co
|
|
|
|
|
|
|
|
| S / SentinelOne, Inc.
|
|
|
|
|
|
|
|
| CMPX / Compass Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BHIL / Benson Hill, Inc.
|
|
|
|
|
|
|
|
| TWLO / Twilio Inc.
|
|
|
|
|
|
|
|
| RCUS / Arcus Biosciences, Inc.
|
|
|
|
|
|
|
|
| RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| MGTA / Magenta Therapeutics Inc
|
|
|
|
|
|
|
|
| SPGI / S&P Global Inc.
|
|
|
|
|
|
|
|
| BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
| GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TOST / Toast, Inc.
|
|
|
|
|
|
|
|
| LYFT / Lyft, Inc.
|
|
|
|
|
|
|
|
| OPRT / Oportun Financial Corporation
|
|
|
|
|
|
|
|
| DBTX / Decibel Therapeutics Inc
|
|
|
|
|
|
|
|
| OMIC / Singular Genomics Systems, Inc.
|
|
|
|
|
|
|
|
| ME / 23andMe Holding Co.
|
|
|
|
|
|
|
|
| WE / WeWork Inc - Class A
|
|
|
|
|
|
|
|
| EQRX / EQRx Inc
|
|
|
|
|
|
|
|
| AMPL / Amplitude, Inc.
|
|
|
|
|
|
|
|
| KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
| PL / Planet Labs PBC
|
|
|
|
|
|
|
|
| EVLO / Evelo Biosciences, Inc.
|
|
|
|
|
|
|
|
| HOOD / Robinhood Markets, Inc.
|
|
|
|
|
|
|
|
| SANA / Sana Biotechnology, Inc.
|
|
|
|
|
|
|
|
| TNYA / Tenaya Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| DUOL / Duolingo, Inc.
|
|
|
|
|
|
|
|
| FRSH / Freshworks Inc.
|
|
|
|
|
|
|
|
| NEWR / New Relic Inc
|
|
|
|
|
|
|
|
| RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IVVD / Invivyd, Inc.
|
|
|
|
|
|
|
|
| HYPR / Hyperfine, Inc.
|
|
|
|
|
|
|
|
| QNCX / Quince Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IONQ / IonQ, Inc.
|
|
|
|
|
|
|
|
| ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
